Tender detail

Conclusion of a non-exclusive pharmaceutical discount agreement for indacaterol and glycopyrronium bromide (1 December 2026–30 November 2028)

Summary

DAK-Gesundheit intends to conclude pharmaceutical discount agreements with interested pharmaceutical companies for medicines containing the active ingredients indacaterol and glycopyrronium bromide (ATC R03AL04). The agreements are scheduled to take effect on 1 December 2026 and run until 30 November 2028, but will end earlier if an exclusive agreement for the active ingredient takes effect.

Reference number
e095714f-f8a6-4f0b-801c-4ae91ace21dd
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2028-10-05
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.